NEJM: US Firms Can’t Ignore EU AI Act

Far-reaching AI regulations issued in the European Union also hold implications for US firms, a recent journal article claims. Companies that sell, use, import or distribute AI devices in the EU are all affected.

US EU Cooperation Gears
(Rawf8/Shutterstock)

More from Medtech Insight

More from Policy & Regulation